Gene Expression Analysis Market Global Trends, Market Share, Industry Size, Growth, Opportunities, a
Global†gene expression analysis market†is forecasted to value over USD 7.6 billion by 2026 end and register a CAGR of over 8.4% by 2026 end. The increased focus towards the healthcare framework along...
Global†gene expression analysis market†is forecasted to value over USD 7.6 billion by 2026 end and register a CAGR of over 8.4% by 2026 end.
The increased focus towards the healthcare framework alongside the rapid adoption of the latest advanced technologies in drug development and modern diagnostics is driving the gene expression analysis market. Furthermore, the optimization of gene profiling study for the advancement of novel therapeutics due to more efficient time and affordable cost is boosting the market growth. A recent fall in the price of genetic sequencing has allowed more availability of the clinical application, thus propelling the market. The implementation of the Precision Medicine Initiative (PMI) has fueled the deployment of advanced medical tools in the healthcare sector which positively influences the market. The invention of cap analysis of gene expression has played a vital role in overcoming the limitations of microarrays. Cap Analysis of Gene Expression (CAGE) permits in-depth mapping of human recordings. This has led to a frequent enhancement of products and rise in the implementation of novel platforms which play an important role in the escalation of the market.
The market is bifurcated into by process, by product, by capacity, by technique, by application, and by region. In terms of process, PCR analysis is expected to hold a vast share of the market. Multiple types of research opt for PCR analysis to examine expressions related to multiple microorganisms and genes. Easy integration of PCR analysis with another immunoprecipitation assay such as ChIP-PCR to amend its performance is also anticipated to stimulate the market.
In terms of products, kits & reagents are expected to dominate the market growth. Kits and reagents, when compared to others, are more effective and are available at affordable prices. The introduction of novel and efficient reagents is expected to bolster the market.
Based on capacity, low to mid plex is expected to show notable growth. Advancements in genetic engineering and stem cell research has enhanced the development of low to mid plex thus inflating the market. Increased research in the field of stem cell therapy, single-cell analysis, cancer genomics, and regenerative therapy is thriving in the market.
Based on application, drug discovery and development is expected to be the front runner of the market owing to increasing preference towards drug response testing for various diseases such as cardiac conditions, rare genetic disorders, and tuberculosis.
Based on the technique, RNA expression is the front runner of the market. The rising demand for DNA microarrays and PCR analysis has resulted in the inflation of the market. Besides, the integration of immunoprecipitation assay with these techniques has also positively influenced the market. The emergence of upcoming next-generation sequencing is expected to propagate the market growth.
North America dictates the market growth. The presence of developed healthcare infrastructure and prominent players in the region is driving the market. Besides, the increasing government support and demand for precision medicine is also complementing the growth of the market in the region. The increasing prevalence of genetic disorders alongside rapid advancement in the biotechnology field is also playing a vital part in the expansion of the market in the region.
Asia-Pacific region is projected to be a lucrative region owing to the imposition of government policies that favour foreign investments. Countries like Japan, India, and China are allowing the considerable number of prominent players to invest in gene therapy thus propelling the market in the region.
Major players of the market Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, QIAGEN N.V, PerkinElmer, BGI. GE Healthcare, Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc. and Pacific,†Biosciences of California, Inc.
™††††††Biorad acquired RainDance Technologies in 2017. RainDance Technologies is a droplet-based PCR systems manufacturers and has an accurate portfolio
™††††††Thermo Fisher Scientific acquired Affymetrix. The move bolstered Thermo Fisher Scientific's foothold in genetic analysis and cellular products
FutureWise Key Takeaways:
Request a Sample Report†@†https://www.futurewiseresearch.com/request-sample.aspx?id=3370&page=requestsample
Global Gene Expression Analysis Market Segmentation:
™††††††In vitro Transcription/Nuclear Run-On Assays
™††††††Gel Shift Assays
™††††††Chromatin Immunoprecipitation (ChIP)
™††††††2-D Gel Electrophoresis
Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3370&page=askfordiscount
Objectives of the Study:
Inquire further details about this report at:†firstname.lastname@example.org
Source: Free Articles from ArticlesFactory.com
ABOUT THE AUTHOR
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
Company Name:†FutureWise Research